Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL)

NCT02192021 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous T Cell Lymphoma

Interventions

DRUG: Micro needle array-Doxorubicin (MNA-D)

Sponsor

Falo, Louis, MD